SUO 2018 Kidney Cancer

Viewing 1-17 of 17 articles

SUO 2018: Debate: Enucleo-Resection vs. Wedge Resection for Partial Nephrectomy in 4 cm tumors - PRO

SUO 2018: Debate: Enucleo-Resection vs. Wedge Resection for Partial Nephrectomy in 4 cm tumors - CON

SUO 2018: Hereditary Kidney Cancer and Genetic Testing

SUO 2018: Cytoreductive Nephrectomy Is No Longer Standard of Care in Patients with Metastatic Renal Cell Carcinoma

SUO 2018: Surgical Perspective on Management for Hereditary Kidney Cancer

SUO 2018: A Phase 3, Randomized, Double Blind, Placebo Controlled Study of Enzalutamide in Men with Nonmetastatic Castration-Resistant Prostate Cancer: Post Hoc Analysis of PROSPER by Prior Definitive Surgery

SUO 2018: There Is Still a Role for Cytoreduction

SUO 2018: Clinicopathologic Correlates of Copy Number Variations in Clear Cell Renal Cell Carcinoma: A Study of 178 Samples Profiled with Next-generation Sequencing

SUO 2018: Renal Biopsy Cell Cycle Proliferation (CCP) Score Predicts Adverse Surgical Pathology in Renal Cell Carcinoma

SUO 2018: Metastasectomy: Update on the Evidence

SUO 2018: Three-year Renal Functional Outcomes of Patients Enrolled in the Intravenous Mannitol Versus Placebo During Partial Nephrectomy Randomized Controlled Trial

SUO 2018: Panel Discussion: Revisiting Cyroreductive Nephrectomy in the Current Era

SUO 2018: Neoadjuvant and Adjuvant Therapy: Current Guidelines and Practical Approach for the Urologic Surgeon

SUO 2018: Adjuvant Therapies in Kidney Cancer: FDA Panel Insights

SUO 2018: Phase III Trial of Intravenous Mannitol vs. Placebo During Nephron Sparing Surgery: 3 Year Outcomes

SUO 2018: The Microbiome in Kidney Cancer

SUO 2018: Immune Response in Patients With Metastatic Renal Cell Carcinoma Treated With AdGMCA9